Profile picture

Doctor Daniel Jorge Nascimento Matos

Hospital de Santa Cruz, Carnaxide (Portugal)
Follow
Logo ESC

Contributor content

Ventricular tachycardia ablation in nonischemic cardiomyopathy
Presentation
Ventricular tachycardia ablation in nonischemic cardiomyopathy
Ventricular tachycardia ablation in nonischemic cardiomyopathy
Presentation
Ventricular tachycardia ablation in nonischemic cardiomyopathy
A new electrophysiological triad for atrial flutter critical isthmus identification and localization
Presentation
A new electrophysiological triad for atrial flutter critical isthmus identification and localization
Electrical anatomy of the left atrium during atrial fibrillation
Presentation
Electrical anatomy of the left atrium during atrial fibrillation
Combined endocardial and epicardial ventricular tachycardia ablation for ischemic and nonischemic dilated cardiomyopathy
Presentation
Combined endocardial and epicardial ventricular tachycardia ablation for ischemic and nonischemic dilated cardiomyopathy
Relationship between epicardial fat and left atrium fibrosis in patients with atrial fibrillation
Presentation
Relationship between epicardial fat and left atrium fibrosis in patients with atrial fibrillation
Epicardial fat volume outperforms classic clinical scores for predicting atrial fibrillation relapse after pulmonary vein isolation
Presentation
Epicardial fat volume outperforms classic clinical scores for predicting atrial fibrillation relapse after pulmonary vein isolation
A machine-learning algorithm to predict atrial fibrillation recurrence after a pulmonary vein isolation procedure
Presentation
A machine-learning algorithm to predict atrial fibrillation recurrence after a pulmonary vein isolation procedure
Who is too old for epicardial fat volume quantification?
Presentation
Who is too old for epicardial fat volume quantification?
Long term safety analysis of transvenous vs subcutaneous implantable cardioverter defibrillators: a propensity score matched analysis
Presentation
Long term safety analysis of transvenous vs subcutaneous implantable cardioverter defibrillators: a propensity score matched analysis

ESC 365 is supported by